海科新源 reported revenue of ¥3.36B for the period ended 2026-06-30, +45.0% year on year. Net income was ¥0.43B, a 12.8% net margin on a 20.9% gross margin. The largest revenue line is 碳酸酯系列 at 59% of the total. Free cash flow for the period was ¥-0.09B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥3.36B | +45.0% |
| Gross profit | ¥0.70B | — |
| Operating income | ¥0.47B | — |
| Net income | ¥0.43B | — |
| Gross margin | 20.9% | Net margin 12.8% |
| Revenue Q/Q | +22.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 碳酸酯系列 | ¥1.97B | 58.5% |
| 其他类 | ¥0.78B | 23.1% |
| 丙二醇 | ¥0.62B | 18.3% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥2.66B | 79.1% |
| R&D | ¥0.12B | 3.5% |
| SG&A | ¥0.05B | 1.6% |
| Tax & other | ¥0.04B | 1.1% |
| Item | Amount |
|---|---|
| Total assets | ¥8.59B |
| Total liabilities | ¥5.39B |
| Shareholders' equity | ¥3.20B |
| Equity / assets | 37.2% |
| Operating cash flow | ¥-0.07B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥-0.09B |
| Cash conversion (OCF / net income) | -23% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
三博脑科 ・ 美硕科技 ・ 新巨丰 ・ 富乐德 ・ 东利机械 ・ 卓创资讯 ・ 远翔新材 ・ 川宁生物 ・ 华如科技 ・ 真兰仪表 ・ 朗坤科技 ・ 西测测试
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies